Notable Labs, Ltd.
NTBL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $310 | $8 | $285 | $922 |
| % Growth | 3,775% | -97.2% | -69.1% | – |
| Cost of Goods Sold | $197 | $1,162 | $1,621 | $1,588 |
| Gross Profit | $113 | -$1,154 | -$1,336 | -$666 |
| % Margin | 36.5% | -14,425% | -468.8% | -72.2% |
| R&D Expenses | $4,706 | $7,776 | $11,472 | $18,462 |
| G&A Expenses | $10,064 | $5,156 | $5,727 | $0 |
| SG&A Expenses | $10,064 | $5,156 | $5,727 | $5,355 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1,483 | $862 | $0 |
| Operating Expenses | $14,770 | $12,932 | $17,199 | $23,817 |
| Operating Income | -$14,657 | -$12,924 | -$16,914 | -$24,483 |
| % Margin | -4,728.1% | -161,550% | -5,934.7% | -2,655.4% |
| Other Income/Exp. Net | $3,393 | -$1,483 | $862 | $258 |
| Pre-Tax Income | -$11,264 | -$14,407 | -$16,052 | -$24,225 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,264 | -$14,407 | -$16,052 | -$24,225 |
| % Margin | -3,633.5% | -180,087.5% | -5,632.3% | -2,627.4% |
| EPS | -5.03 | -6.5 | -0.22 | -0.48 |
| % Growth | 22.6% | -2,854.5% | 54.2% | – |
| EPS Diluted | -5.03 | -6.5 | -0.22 | -0.48 |
| Weighted Avg Shares Out | 2,240 | 2,216 | 73,049 | 50,531 |
| Weighted Avg Shares Out Dil | 2,240 | 2,216 | 73,049 | 50,531 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $363 |
| Interest Expense | $0 | $0 | $0 | $105 |
| Depreciation & Amortization | $257 | $1,058 | $1,256 | $1,194 |
| EBITDA | -$14,400 | -$12,601 | -$16,588 | -$22,926 |
| % Margin | -4,645.2% | -157,512.5% | -5,820.4% | -2,486.6% |